https://www.thebodypro.com/article/bristol-myers-squibb-gilead-announce-data-supporting-bioequivalen
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada)News

Bristol-Myers Squibb and Gilead Announce Data Supporting Bioequivalence for Single-Pill Fixed-Dose Regimen of Sustiva (Efavirenz) and Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate)

Companies Anticipate Filing New Drug Application in Second Quarter of 2006

    Bristol-Myers Squibb Company and Gilead Sciences, Inc.